Interleukin 6 and complement serum level study in Parkinson's disease

Publikace nespadá pod Přírodovědeckou fakultu, ale pod Středoevropský technologický institut. Oficiální stránka publikace je na webu muni.cz.

Autoři

VESELÝ Branislav DUFEK Michal THON Vojtěch BROZMAN M. KIRALOVA S. HALASZOVA T. KORIŤÁKOVÁ Eva REKTOR Ivan

Druh Článek v odborném periodiku
Časopis / Zdroj Journal of Neural Transmission
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
WWW https://link.springer.com/article/10.1007%2Fs00702-018-1857-5
Doi http://dx.doi.org/10.1007/s00702-018-1857-5
Klíčová slova Complement; Interleukin 6; Parkinson's disease
Popis The objective of this study is to assess whether elevation of serum inflammatory markers levels may indicate the progression of clinical impairment in Parkinson's disease (PD) patients. In 47 PD patients, the serum levels of the C3 and C4 part of the complement and Interleukin-6 (IL-6) were measured. The results at baseline and after 2 years were correlated with scales measuring memory, depression, motor symptoms, and quality of life. Patients with higher levels of C3 and C4 at baseline had decreased quality of life, verbal ability, and memory. Patients with higher IL-6 at baseline showed worse depression scores at 2 years. Patients with persistently higher levels of C3 and C4 at 2 years had worse quality of life and memory ability. Uncorrected p values are reported due to the exploratory nature of the study. The results indicate an impact of inflammation on non-motor signs and quality of life in PD. The increase of levels of serum inflammatory biomarkers may indicate the progression of non-motor impairment in PD.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.